This was the stock's second consecutive day of losses.

The high cost of pharmaceutical products coupled with a lack of federally funded HIV programs create barriers for preexposure prophylaxis (PrEP) access according to Jeremiah Johnson, executive ...

Shares of MEI Pharma hit a 52-week high after the company said a $100 million private placement will be used to adopt the cryptocurrency Litecoin as its treasury reserved asset. The stock was up 52% ...

GSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP) (“MEI”), in which it will serve as both strategic advisor and digital ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

The HHS secretary and four of his advisers earned at least $3.2 million from their work opposing Big Pharma and promoting ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...

Whether Kennedy hands down a ban or one is passed on Capitol Hill, pharma marketing is set to undergo a significant transformation.

Simulations Plus dipped after Q3 2025 on guidance cuts, but core software strength and long-term growth drivers remain. Find ...

Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support ...

Catching up with Jon Maschmeyer, partner at Permira, to learn more about the growth strategy for Valeris, which formed from the Permira portfolio company PharmaCord and Odyssey Investment ...